Standard BioTools ROA 2010-2024 | LAB

Current and historical return on assets (ROA) values for Standard BioTools (LAB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Standard BioTools ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-06-30 $-0.17B $0.71B -30.71%
2024-03-31 $-0.14B $0.78B -30.29%
2023-12-31 $-0.08B $0.32B -21.58%
2023-09-30 $-0.08B $0.34B -20.86%
2023-06-30 $-0.08B $0.36B -21.92%
2023-03-31 $-0.13B $0.37B -32.39%
2022-12-31 $-0.19B $0.39B -50.07%
2022-09-30 $-0.18B $0.42B -50.75%
2022-06-30 $-0.16B $0.44B -51.34%
2022-03-31 $-0.12B $0.27B -41.50%
2021-12-31 $-0.06B $0.28B -20.50%
2021-09-30 $-0.07B $0.28B -22.65%
2021-06-30 $-0.06B $0.29B -19.32%
2021-03-31 $-0.06B $0.31B -18.14%
2020-12-31 $-0.05B $0.33B -17.38%
2020-09-30 $-0.05B $0.32B -16.55%
2020-06-30 $-0.06B $0.28B -19.89%
2020-03-31 $-0.06B $0.29B -20.22%
2019-12-31 $-0.07B $0.27B -23.44%
2019-09-30 $-0.07B $0.27B -23.34%
2019-06-30 $-0.07B $0.28B -24.40%
2019-03-31 $-0.07B $0.29B -25.68%
2018-12-31 $-0.06B $0.30B -21.75%
2018-09-30 $-0.05B $0.25B -20.22%
2018-06-30 $-0.06B $0.26B -19.86%
2018-03-31 $-0.06B $0.27B -19.86%
2017-12-31 $-0.06B $0.29B -20.87%
2017-09-30 $-0.07B $0.29B -23.27%
2017-06-30 $-0.07B $0.28B -24.06%
2017-03-31 $-0.07B $0.29B -23.49%
2016-12-31 $-0.08B $0.31B -23.30%
2016-09-30 $-0.07B $0.32B -20.78%
2016-06-30 $-0.06B $0.34B -16.90%
2016-03-31 $-0.06B $0.35B -15.29%
2015-12-31 $-0.05B $0.37B -13.84%
2015-09-30 $-0.05B $0.38B -12.99%
2015-06-30 $-0.06B $0.39B -13.98%
2015-03-31 $-0.05B $0.40B -13.24%
2014-12-31 $-0.05B $0.41B -12.76%
2014-09-30 $-0.05B $0.41B -13.72%
2014-06-30 $-0.04B $0.42B -13.78%
2014-03-31 $-0.03B $0.43B -14.58%
2013-12-31 $-0.02B $0.12B -14.91%
2013-09-30 $-0.02B $0.11B -14.13%
2013-06-30 $-0.02B $0.11B -14.04%
2013-03-31 $-0.02B $0.11B -16.63%
2012-12-31 $-0.02B $0.11B -21.80%
2012-09-30 $-0.02B $0.12B -22.89%
2012-06-30 $-0.02B $0.07B -25.50%
2012-03-31 $-0.02B $0.07B -26.33%
2011-12-31 $-0.03B $0.08B -36.15%
2011-09-30 $-0.03B $0.08B -42.91%
2011-06-30 $-0.03B $0.09B -52.63%
2011-03-31 $-0.03B $0.10B -78.87%
2010-12-31 $-0.02B $0.03B -144.68%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.763B $0.106B
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $10.500B 0.00
Hims & Hers Health (HIMS) United States $5.733B 148.28
Inspire Medical Systems (INSP) United States $5.716B 178.27
Axonics (AXNX) United States $3.603B 1762.25
IRhythm Technologies (IRTC) United States $2.729B 0.00
Privia Health (PRVA) United States $2.710B 225.80
Enovis (ENOV) United States $2.621B 17.77
Omnicell (OMCL) United States $2.264B 74.08
Azenta (AZTA) United States $2.250B 112.17
10x Genomics (TXG) United States $1.898B 0.00
Schrodinger (SDGR) United States $1.620B 0.00
Clover Health Investments (CLOV) United States $1.617B 0.00
Phreesia (PHR) United States $1.235B 0.00
Fulgent Genetics (FLGT) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.569B 0.00
Definitive Healthcare (DH) United States $0.528B 91.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.278B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.261B 0.00
TruBridge (TBRG) United States $0.234B 67.96
P3 Health Partners (PIII) United States $0.140B 0.00
American Well (AMWL) United States $0.136B 0.00
EUDA Health Holdings (EUDA) Singapore $0.098B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
111 (YI) China $0.056B 0.00
CareCloud (CCLD) United States $0.051B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.017B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00